StockPro
Home
Stocks
News
Toggle theme
Mmtec Inc
$ 2.21
1.906 (626.98%)
Solid Power Inc - Class A
$ 8.51
2.895 (51.56%)
Wheeler Real Estate Investment Trust Inc
$ 119.5
37.5 (45.74%)
SMX (Security Matters) Plc - Class A
$ 2.11
0.64 (43.54%)
Entravision Communications Corp - Class A
$ 2.835
0.855 (43.19%)
Sonnet BioTherapeutics Holdings Inc
$ 4.55
1.35 (42.19%)
Cheer Holding Inc
$ 0.074
-0.062 (45.58%)
Biohaven Ltd
$ 8.335
-5.615 (40.25%)
TREX Co. Inc
$ 32.42
-14.62 (31.07%)
Soleno Therapeutics Inc
$ 46.967
-16.883 (26.44%)
Genenta Science SpA ADR
https://www.genenta.com
Stock Exchange:
NASDAQ
Sector:
HEALTHCARE
Market Cap:
$ 52.02Million
Ticker Symbol:
GNTA
Stock
Options
Loading...
Price
$ 2.46
6.96%
Open
2.33
High
2.56
Low
2.3102
Volume
133152
Wed Nov 05 2025
Stock Technicals
1 Year Return
-0.602
52 Week High
6.2
52 Week Low
2.1
Show More
SMA
RSI
Time Series
South China Morning Post
China's chief space contractor readies plans for tourism programme
0 hours ago
Benzinga
Viasat Successfully Tests HaloNet Launch Telemetry Solution for NASA Onboard Blue Origin's New Glenn - Viasat ( NASDAQ:VSAT )
0 hours ago
Benzinga
TradFi Meets Crypto: Stablecoins, Speed - And The New Market Order
0 hours ago
Benzinga
If You Invested $1000 In Tesla Stock 15 Years Ago, You Would Have This Much Today - Tesla ( NASDAQ:TSLA )
0 hours ago
Benzinga
With Layoffs Spreading Across Industries, These Careers Are Still 'Doing Fine Right Now'-And Some Are Surprisingly Easy To Get Into - FedEx ( NYSE:FDX )
1 hours ago
Benzinga
$100 Invested In Broadcom 5 Years Ago Would Be Worth This Much Today - Broadcom ( NASDAQ:AVGO )
1 hours ago
South China Morning Post
Stick with emerging-market stocks, especially in China, AI: UBS
1 hours ago
Benzinga
"LEQEMBI®" ( lecanemab ) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom - Biogen ( NASDAQ:BIIB )
1 hours ago
GlobeNewswire
Cabot Corporation Board Declares Dividend
1 hours ago
GlobeNewswire
"LEQEMBI®" ( lecanemab ) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom
1 hours ago